The field of precision medicine has revolutionized our understanding and treatment of diseases, particularly in the realm of cardiopulmonary disorders. This evolving paradigm shift places an emphasis on individualized care strategies that can dramatically improve patient outcomes. Current approaches focus on honing methodologies to further characterize patient conditions, enhance diagnostic acumen, and tailor therapeutic interventions along the granularity of precision medicine. A cornerstone in this framework has been the integration of biomarkers, which offer a non-invasive, economical, and consistent means to dissect the intricate pathophysiological processes that underlie various disease states. Although still an emerging practice, biomarker application has transcended preliminary trials to become a foundational component in diagnosing acute cardiovascular events, with significant utility noted in clinical emergency settings for patients exhibiting prevalent symptoms like chest pain or dyspnea.

Recent advances have identified novel imaging-based biomarkers pivotal to cardiovascular diagnostics and treatment protocols. Tools such as lung ultrasound and cardiovascular risk surrogates, including flow-mediated dilation and pulse-wave velocity, have emerged as valuable assets in this domain. The commitment of the scientific community to unveiling and validating additional biomarkers is immense, highlighting both the opportunities for clinical breakthroughs and the necessity for continued focused research. While listing all these biomarkers comprehensively is implausible given their dynamic nature, their influence is undeniable in the ongoing transformation of personalized care.

This Research Topic aims to consolidate studies that push the boundaries in cardiopulmonary diagnostics and prognostics, leveraging both traditional and innovative biomarkers. To gather further insights in the area of cardiopulmonary disease management, we welcome articles addressing, but not limited to, the following themes:

o Emerging imaging biomarkers in cardiopulmonary care

o Utilization of non-invasive biomarkers for rapid diagnostics

o Integration of biomarker discoveries in clinical practice

o Prognostic implications of novel biomarkers in chronic cardiovascular diseases

o Case studies demonstrating personalized treatment modifications based on biomarker data

This collection includes original research articles, high-quality reviews, and meta-analyses spanning clinical and functional studies.

This is Volume II of the Research Topic, building on the strong response to Volume I. It continues the same scope and welcomes new submissions on the themes above, alongside any emerging biomarker research that extends the discussion from the first volume.

Are you interested in contributing a manuscript to this Research Topic?

Advancements in Precision Medicine - Diagnostic and Prognostic Innovations for Cardiopulmonary Conditions: Volume II